Home › Open-Angle Glaucoma › California
Open-Angle Glaucoma clinical trials in California
9 studies for Open-Angle Glaucoma are looking for participants at sites in California.
Cities in California
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
- LA Glaucoma Group /ID# 268444, Culver City
- North Bay Eye Associates /ID# 277071, Petaluma
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 28, 2026 · NCT06822738A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- National Clinical Trials, Beverly Hills
- United medical research institute, Inglewood
- Eye research foundation, Inc., Newport Beach
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07661329Hydrus® Microstent New Enrollment Post-Approval Study
- Sacramento Eye Consultants, Sacramento
Recruiting
Ages 45 and older · All sexes · Updated Sep 22, 2026 · NCT04553523Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
- Global Research Management, Inc., Glendale
RecruitingPhase 1
Ages 40 to 85 · All sexes · Updated May 19, 2026 · NCT07290244Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Sacramento Eye Consultants, Sacramento
Recruiting
Ages 45 and older · All sexes · Updated Dec 15, 2025 · NCT07220876Electrical Stimulation for Vision Neuroenhancement in Glaucoma
- Byers Eye Institute at Stanford University, Palo Alto
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT06685211Diagnostic Innovations in Glaucoma Study
- UCSD, Hamilton Glaucoma Center, La Jolla
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 24, 2025 · NCT00221897Electrical Stimulation for the Treatment of Optic Neuropathies
- Byers Eye Institute, Palo Alto
Recruiting
Ages 18 and older · All sexes · Updated Jul 8, 2025 · NCT05626426Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Eye Research Foundation Inc., Newport Beach
- North Bay Eye Associates, Inc., Petaluma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 10, 2022 · NCT05401357From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.